ALCHEMIA (ASX: ACL) is getting a new face.
The drug discovery and development company has announced the departure of Thomas Liquard as CEO.
In the interim, former ACL CEO Tracie Ramsdale will step up from a non-executive director role into an executive director capacity.
The company noted in an announcement that Ramsdale’s leadership will help them during this transition, and ended with thanking Liquard “for his efforts and wishing him well for the future”.
ALCHEMIA'S CEO DEPARTS
11 November 2014
)
Latest News
From $13,000 to $20 million: how a PCOS diagnosis and a pair of scissors built Xali Organics
Inspired by a medical diagnosis and driven by innovative marketing,...
Cedar Woods secures $63.4m in new land acquisitions as record presales underpin pipeline push
Perth-headquartered residential developer Cedar Woods Properties (A...
Australia's long-term beer decline hits home as Lion plans to close Boag's brewery in Launceston
Australia's decades-long decline in beer consumption has claime...
Downer EDI seals $310m Transurban contract to maintain Sydney motorway network
Infrastructure services group Downer EDI (ASX: DOW) has secured con...
Propel Funeral Partners expands New Zealand footprint with trio of acquisitions worth $9.1m
Sydney-based death care provider Propel Funeral Partners (ASX: PFP)...
)
Partner Content
For most Australian homeowners, the house gets the attention and the land gets taken fo...
Ventures & VisionariesAdvertisement
